BR0208771A - Peptìdeo ou poliptìdeo isolados e seus derivados, ácido nucléico codificando o mesmo, vacina copreendendo o mesmo, ácido nucléico codificando o mesmo, vetor compreendendo o referido ácido nucléico, célula hospedeira compreendendo o referido ácido nucléico, composição farmacêutica compreendendo o referido peptìdeo ou polipeptìdeo, método para tratamento ou prevençao de câncer utilizando a referida composição farmacêutica e método para induzir ou magnificar uma resposta imunológica utilizando a referida composição farmacêutica - Google Patents
Peptìdeo ou poliptìdeo isolados e seus derivados, ácido nucléico codificando o mesmo, vacina copreendendo o mesmo, ácido nucléico codificando o mesmo, vetor compreendendo o referido ácido nucléico, célula hospedeira compreendendo o referido ácido nucléico, composição farmacêutica compreendendo o referido peptìdeo ou polipeptìdeo, método para tratamento ou prevençao de câncer utilizando a referida composição farmacêutica e método para induzir ou magnificar uma resposta imunológica utilizando a referida composição farmacêuticaInfo
- Publication number
- BR0208771A BR0208771A BR0208771-5A BR0208771A BR0208771A BR 0208771 A BR0208771 A BR 0208771A BR 0208771 A BR0208771 A BR 0208771A BR 0208771 A BR0208771 A BR 0208771A
- Authority
- BR
- Brazil
- Prior art keywords
- nucleic acid
- same
- pharmaceutical composition
- polypeptide
- peptide
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 14
- 102000039446 nucleic acids Human genes 0.000 title abstract 8
- 108020004707 nucleic acids Proteins 0.000 title abstract 8
- 150000007523 nucleic acids Chemical class 0.000 title abstract 8
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 6
- 229920001184 polypeptide Polymers 0.000 title abstract 6
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 6
- 230000028993 immune response Effects 0.000 title abstract 3
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 201000011510 cancer Diseases 0.000 title abstract 2
- 230000001939 inductive effect Effects 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 230000002265 prevention Effects 0.000 abstract 2
- 102000014914 Carrier Proteins Human genes 0.000 abstract 1
- 108010078791 Carrier Proteins Proteins 0.000 abstract 1
- 101100346929 Homo sapiens MUC1 gene Proteins 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 102000057860 human MUC1 Human genes 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4727—Mucins, e.g. human intestinal mucin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001169—Tumor associated carbohydrates
- A61K39/00117—Mucins, e.g. MUC-1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28013701P | 2001-04-02 | 2001-04-02 | |
| PCT/US2002/010155 WO2002078607A2 (en) | 2001-04-02 | 2002-04-02 | Mucin peptide with immunoenhancing properties |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0208771A true BR0208771A (pt) | 2004-07-06 |
Family
ID=23071833
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0208771-5A BR0208771A (pt) | 2001-04-02 | 2002-04-02 | Peptìdeo ou poliptìdeo isolados e seus derivados, ácido nucléico codificando o mesmo, vacina copreendendo o mesmo, ácido nucléico codificando o mesmo, vetor compreendendo o referido ácido nucléico, célula hospedeira compreendendo o referido ácido nucléico, composição farmacêutica compreendendo o referido peptìdeo ou polipeptìdeo, método para tratamento ou prevençao de câncer utilizando a referida composição farmacêutica e método para induzir ou magnificar uma resposta imunológica utilizando a referida composição farmacêutica |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US7285282B2 (enExample) |
| EP (1) | EP1372691B1 (enExample) |
| JP (2) | JP4223813B2 (enExample) |
| KR (1) | KR20030092044A (enExample) |
| CN (1) | CN1525864A (enExample) |
| AT (1) | ATE376836T1 (enExample) |
| BR (1) | BR0208771A (enExample) |
| CA (1) | CA2443045A1 (enExample) |
| DE (1) | DE60223232T2 (enExample) |
| NZ (1) | NZ528234A (enExample) |
| WO (1) | WO2002078607A2 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1301267C (zh) * | 2005-06-21 | 2007-02-21 | 中国人民解放军军事医学科学院附属医院 | Muc1粘蛋白的一个模拟表位肽及其编码dna与应用 |
| WO2008093166A2 (en) * | 2006-05-11 | 2008-08-07 | Ghent University | Sialoadhesin-related compositions and methods |
| CN112574283B (zh) * | 2020-12-07 | 2022-07-05 | 湖北文理学院 | 一种人muc1特异性结合多肽及其提取方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2668064B1 (fr) * | 1990-10-23 | 1994-12-16 | Transgene Sa | Composition pharmaceutique pour le traitement ou la prevention d'une tumeur maligne. |
-
2002
- 2002-04-02 JP JP2002576876A patent/JP4223813B2/ja not_active Expired - Fee Related
- 2002-04-02 CN CNA028077784A patent/CN1525864A/zh active Pending
- 2002-04-02 DE DE60223232T patent/DE60223232T2/de not_active Expired - Fee Related
- 2002-04-02 NZ NZ528234A patent/NZ528234A/en unknown
- 2002-04-02 CA CA002443045A patent/CA2443045A1/en not_active Abandoned
- 2002-04-02 US US10/113,800 patent/US7285282B2/en not_active Expired - Fee Related
- 2002-04-02 WO PCT/US2002/010155 patent/WO2002078607A2/en not_active Ceased
- 2002-04-02 KR KR10-2003-7012901A patent/KR20030092044A/ko not_active Withdrawn
- 2002-04-02 AT AT02757916T patent/ATE376836T1/de not_active IP Right Cessation
- 2002-04-02 EP EP02757916A patent/EP1372691B1/en not_active Expired - Lifetime
- 2002-04-02 BR BR0208771-5A patent/BR0208771A/pt not_active IP Right Cessation
-
2004
- 2004-08-04 US US10/910,612 patent/US20050095675A1/en not_active Abandoned
-
2005
- 2005-04-05 JP JP2005109271A patent/JP2005247861A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| CN1525864A (zh) | 2004-09-01 |
| US7285282B2 (en) | 2007-10-23 |
| US20050095675A1 (en) | 2005-05-05 |
| DE60223232T2 (de) | 2008-08-14 |
| JP4223813B2 (ja) | 2009-02-12 |
| EP1372691A2 (en) | 2004-01-02 |
| JP2004532018A (ja) | 2004-10-21 |
| WO2002078607A2 (en) | 2002-10-10 |
| EP1372691B1 (en) | 2007-10-31 |
| WO2002078607A3 (en) | 2003-03-27 |
| ATE376836T1 (de) | 2007-11-15 |
| NZ528234A (en) | 2006-01-27 |
| JP2005247861A (ja) | 2005-09-15 |
| EP1372691A4 (en) | 2005-11-09 |
| CA2443045A1 (en) | 2002-10-10 |
| KR20030092044A (ko) | 2003-12-03 |
| US20030166853A1 (en) | 2003-09-04 |
| DE60223232D1 (de) | 2007-12-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Chandy et al. | Peptide blockers of Kv1. 3 channels in T cells as therapeutics for autoimmune disease | |
| US5696078A (en) | Methods of treating fungal infections using histatin-based peptides | |
| Dalum et al. | Breaking of B cell tolerance toward a highly conserved self protein | |
| ES2584430T3 (es) | Estrategias para prevenir y/o tratar las respuestas inmunitarias a los alofactores solubles | |
| BRPI0208183B8 (pt) | peptídeo antígeno de câncer modificado por wt1 e vacinas para câncer | |
| CY1113379T1 (el) | Πεπτιδια κdr και εμβολια που τα περιλαμβανουν | |
| ES2373055T3 (es) | Péptido antígeno de rechazo de cáncer derivado de glipican-3 (gpc3) para uso en pacientes positivos a la hla-a2 y producto farmacéutico que comprende el antígeno. | |
| ES2112838T3 (es) | Peptidos receptores de celulas t como agentes terapeuticos para enfermedades autoinmunitarias y malignas. | |
| BRPI0010612B8 (pt) | vacinas | |
| BR0210216A (pt) | Holotoxina do cólera imunogênica, mutante (ct-crm), composição imunogênica, métodos para aumentar a resposta imune de um hospedeiro vertebrado a um antìgeno, e para produzir uma holotoxina do cólera imunogênica, mutante, sequência ou molécula de ácido nucleico isolado e purificado, célula hospedeira, e, uso de uma holotoxina do cólera mutante | |
| BR0308101A (pt) | Vacinas de dna que codificam cea e um ligante de cd40 e seus métodos de uso | |
| ES2398492T3 (es) | Proteínas de fusión que comprenden los antígenos de rechazo tumoral NY-ESO-1 y LAGE-1 | |
| JP3986481B2 (ja) | シャペロニン１０ | |
| LaBella et al. | Lipotropin: Localization by radioimmunoassay of endorphin precursor in pituitary and brain | |
| ATE103297T1 (de) | Peptid, immunogene zusammensetzung und impfstoff oder medizinische zubereitung, eine methode zur immunisierung eines saeugetieres gegen lhrh und methode zur verbesserung von mea. | |
| AU2017225015B2 (en) | Medical Use | |
| ATE205219T1 (de) | Ein verbessertes peptid, immunogene zusammensetzung und impfstoff oder medizinische präparate, eine methode zur immunisierung von tieren gegen das hormon lhrh und analoge des lhrh-tendem-repeat-peptid und deren verwendung als impfstoff | |
| TW434257B (en) | Proteins from mammalian liver and their use in oncology | |
| BR0208771A (pt) | Peptìdeo ou poliptìdeo isolados e seus derivados, ácido nucléico codificando o mesmo, vacina copreendendo o mesmo, ácido nucléico codificando o mesmo, vetor compreendendo o referido ácido nucléico, célula hospedeira compreendendo o referido ácido nucléico, composição farmacêutica compreendendo o referido peptìdeo ou polipeptìdeo, método para tratamento ou prevençao de câncer utilizando a referida composição farmacêutica e método para induzir ou magnificar uma resposta imunológica utilizando a referida composição farmacêutica | |
| JP2008509072A (ja) | 改良型ワクチン用のポリペプチド‐アジュバント複合体 | |
| Ellerman et al. | Immunocontraceptive properties of recombinant sperm protein DE: implications for the development of novel contraceptives | |
| HRP20150363T1 (hr) | Kompozicije koje sadrže core-1 pozitivni mikroorganizam i njihova primjena za lijeäśenje ili profilaksu tumora | |
| AR014884A1 (es) | Uso de un conjugado de angiotensina inmunogenico y composicion farmaceutica | |
| CA2158748A1 (en) | Botulinum toxin polypeptides and their use as vaccine enhancing agents | |
| BRPI0613515A2 (pt) | imunomodulação induzida por chaperonina 10 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A,6A E 7A ANUIDADES |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2029 DE 24/11/2009. |